Retraction
Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
Paper Information
Record ID:
49820
Author(s):
Journal:
Publication Date:
September 19, 2022
Retraction Date:
August 02, 2023
(2.3 years years ago)
Subjects:
Institutions:
- Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China
- Department of Clinical Nutrition, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China
- Department of Hepatobiliary and Pancreatic Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9815947Additional Notes:
See also: https://pubpeer.com/publications/C39B386F9A07001C53E6CCC24CC7CF
Citations (9)
9
Total Citations4
Post-Retraction(44.4%)
3
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
650
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Targeting tumor-associated genes, immune response, and circulating tumor cells in intrahepatic cholangiocarcinoma: Therapeutic potential of Atractylodes lancea (Thunb.) DC
Pongsakorn Martviset, Pathanin Chantree, Nisit Tongsiri et al. (5 authors)
PLoS ONE
Open Access
Published: May 2025
650 days after retraction
Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma
Xiuzhi Zhang, Zhefeng Xiao, Xia Zhang et al. (10 authors)
Cancer Cell International
Open Access
Published: Feb 2024
4 citations
4 citations
201 days after retraction
Bioinformatics identification of key microRNA correlated genes for the development and prognosis of hepatocellular carcinoma
Guomiao Su, Yanxi Li, Juan Wang et al. (6 authors)
Research Square (Research Square)
Open Access
Published: Feb 2024
189 days after retraction
Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma
Jiajing Zhao, Zeminshan Luo, Ruizhi Fu et al. (8 authors)
European journal of medical research
Open Access
Published: Dec 2023
8 citations
8 citations
126 days after retraction
Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
Oxidative Medicine And Cellular Longevity
Oxidative Medicine and Cellular Longevity
Open Access
Published: Aug 2023
Same day as retraction
The SLIT/ROBO Pathway in Liver Fibrosis and Cancer
Sreenivasulu Basha, Brady Jin-Smith, Chunbao Sun et al. (4 authors)
Biomolecules
Open Access
Published: May 2023
21 citations
21 citations
93 days before retraction
Development and validation of a coagulation-related genes prognostic model for hepatocellular carcinoma
Wanxia Yang, Hong‐Wei Gao, Jia-Bo Cui et al. (8 authors)
BMC Bioinformatics
Open Access
Published: Mar 2023
4 citations
4 citations
146 days before retraction
Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development
Mario Alba, Brandon Ebright, Brittney Hua et al. (8 authors)
Frontiers in Physiology
Open Access
Published: Feb 2023
15 citations
15 citations
181 days before retraction
Quick Stats
Total Citations:
15
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025